Acetylcholinesterase inhibitors combined with memantine for moderate to severe Alzheimer’s disease: a meta-analysis. Swiss Med Wkly [Internet]. 2019 Jun. 30 [cited 2026 Jan. 11];149(2526):w20093. Available from: https://www.smw.ch/index.php/smw/article/view/2635